These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23810727)

  • 1. Online in vivo dosimetry in high dose rate prostate brchytherapy with MOSkin detectors: in phantom feasibility study.
    Gambarini G; Carrara M; Tenconi C; Mantaut N; Borroni M; Cutajar D; Petasecca M; Fuduli I; Lerch M; Pignoli E; Rosenfeld A
    Appl Radiat Isot; 2014 Jan; 83 Pt C():222-6. PubMed ID: 23810727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards real time in-vivo rectal dosimetry during trans-rectal ultrasound based high dose rate prostate brachytherapy using MOSkin dosimeters.
    Poder J; Howie A; Brown R; Bucci J; Rosenfeld A; Enari K; Schreiber K; Carrara M; Bece A; Malouf D; Cutajar D
    Radiother Oncol; 2020 Oct; 151():273-279. PubMed ID: 32798597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement.
    Legge K; Greer PB; O'Connor DJ; Wilton L; Richardson M; Hunter P; Wilfert A; Martin J; Rosenfeld A; Cutajar D
    Radiat Oncol; 2017 Feb; 12(1):41. PubMed ID: 28241841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
    Anton M; Wagner D; Selbach HJ; Hackel T; Hermann RM; Hess CF; Vorwerk H
    Phys Med Biol; 2009 May; 54(9):2915-31. PubMed ID: 19384000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo dosimetry with a linear MOSFET array to evaluate the urethra dose during permanent implant brachytherapy using iodine-125.
    Bloemen-van Gurp EJ; Haanstra BK; Murrer LH; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1266-72. PubMed ID: 19665317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo rectal wall measurements during HDR prostate brachytherapy with MOSkin dosimeters integrated on a trans-rectal US probe: Comparison with planned and reconstructed doses.
    Carrara M; Tenconi C; Rossi G; Borroni M; Cerrotta A; Grisotto S; Cusumano D; Pappalardi B; Cutajar D; Petasecca M; Lerch M; Gambarini G; Fallai C; Rosenfeld A; Pignoli E
    Radiother Oncol; 2016 Jan; 118(1):148-53. PubMed ID: 26796593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of MOSkin detector for in vivo dose verification during Cobalt-60 high dose-rate intracavitary brachytherapy.
    Jamalludin Z; Jong WL; Abdul Malik R; Rosenfeld A; Ung NM
    Phys Med; 2019 Feb; 58():1-7. PubMed ID: 30824140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo dosimetry using MOSkin detector during Cobalt-60 high-dose-rate (HDR) brachytherapy of skin cancer.
    Jamalludin Z; Jong WL; Ho GF; Rosenfeld AB; Ung NM
    Australas Phys Eng Sci Med; 2019 Dec; 42(4):1099-1107. PubMed ID: 31650362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of rectal dose discrepancies between planned and in vivo dosimetry using MOSkin detector and PTW 9112 semiconductor probe during
    Jamalludin Z; Jong WL; Malik RA; Rosenfeld AB; Ung NM
    Phys Med; 2020 Jan; 69():52-60. PubMed ID: 31830631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility study of using MOSFET detectors for in vivo dosimetry during permanent low-dose-rate prostate implants.
    Cygler JE; Saoudi A; Perry G; Morash C; E C
    Radiother Oncol; 2006 Sep; 80(3):296-301. PubMed ID: 16905209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid state TL detectors for in vivo dosimetry in brachytherapy.
    Gambarini G; Borroni M; Grisotto S; Maucione A; Cerrotta A; Fallai C; Carrara M
    Appl Radiat Isot; 2012 Dec; 71 Suppl():48-51. PubMed ID: 22920417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo dosimetry using a linear Mosfet-array dosimeter to determine the urethra dose in 125I permanent prostate implants.
    Bloemen-van Gurp EJ; Murrer LH; Haanstra BK; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):314-21. PubMed ID: 19100925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry of anal radiation in high-dose-rate brachytherapy for prostate cancer.
    Kälkner KM; Bengtsson E; Eriksson S; Holmberg C; Nilsson S; Levitt S; Lundell M
    Brachytherapy; 2007; 6(1):49-52. PubMed ID: 17284386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials of a urethral dose measurement system in brachytherapy using scintillation detectors.
    Suchowerska N; Jackson M; Lambert J; Yin YB; Hruby G; McKenzie DR
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):609-15. PubMed ID: 21093172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry.
    Toye W; Das R; Kron T; Franich R; Johnston P; Duchesne G
    Radiother Oncol; 2009 May; 91(2):243-8. PubMed ID: 18954914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiconductor real-time quality assurance dosimetry in brachytherapy.
    Carrara M; Cutajar D; Alnaghy S; Espinoza A; Romanyukha A; Presilla S; Tenconi C; Cerrotta A; Fallai C; Safavi-Naeini M; Petasecca M; Kejda A; Lerch M; Corde S; Jackson M; Howie A; Bucci J; Rosenfeld AB
    Brachytherapy; 2018; 17(1):133-145. PubMed ID: 28964727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of MOSkin dosimeters to rectal wall in vivo dosimetry in gynecological HDR brachytherapy.
    Carrara M; Romanyukha A; Tenconi C; Mazzeo D; Cerrotta A; Borroni M; Cutajar D; Petasecca M; Lerch M; Bucci J; Richetti A; Presilla S; Fallai C; Gambarini G; Pignoli E; Rosenfeld A
    Phys Med; 2017 Sep; 41():5-12. PubMed ID: 28499627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution.
    Rutten TP; Lawson JM; Marcu LG
    Phys Med; 2013 Nov; 29(6):662-9. PubMed ID: 22975428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of an in vivo dosimetry-based source tracking method for afterloading brachytherapy - A phantom study.
    Jørgensen EB; Kertzscher G; Buus S; Bentzen L; Hokland SB; Rylander S; Tanderup K; Johansen JG
    Med Phys; 2021 May; 48(5):2614-2623. PubMed ID: 33655555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of using MOSFET detectors for dose verification measurements in an end-to-end
    Persson M; Nilsson J; Carlsson Tedgren Å
    Brachytherapy; 2018; 17(1):227-233. PubMed ID: 29110967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.